TPP1 and juvenile neuronal ceroid lipofuscinosis: For example, cerliponase alfa, or recombinant human tripeptidyl peptidase 1 (TPP1), is a US Food and Drug Administration (FDA)-approved ERT infused through an Ommaya reservoir to treat children with CLN2 Batten disease.180